Basecamp Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Basecamp Wealth Advisors's LLY Position: Q2 2026 in Review
Basecamp Wealth Advisors increased its Eli Lilly (LLY) stake by 0.03% in Q2 2026, buying an estimated $4.09K and bringing the position to 14,478 shares worth $17.4M. The position accounts for 3.23% of the portfolio, ranked #4.
Basecamp Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,584 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Basecamp Wealth Advisors held 14,478 shares of Eli Lilly worth $17.4M as of Q2 2026.
- Basecamp Wealth Advisors bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
- Eli Lilly made up 3.23% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #4 holding.
- Basecamp Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 4,584 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.